相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Obeticholic acid reduces bacterial translocation and inhibits intestinal inflammation in cirrhotic rats
Maria Ubeda et al.
JOURNAL OF HEPATOLOGY (2016)
The FXR Agonist Obeticholic Acid Prevents Gut Barrier Dysfunction and Bacterial Translocation in Cholestatic Rats
Len Verbeke et al.
AMERICAN JOURNAL OF PATHOLOGY (2015)
Efficacy of Obeticholic Acid in Patients With Primary Biliary Cirrhosis and Inadequate Response to Ursodeoxycholic Acid
Gideon M. Hirschfield et al.
GASTROENTEROLOGY (2015)
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
Brent A. Neuschwander-Tetri et al.
LANCET (2015)
In search of the magic bullet: can liver inflammation and fibrosis be reversed with medications?
Henning W. Zimmermann et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2015)
Obeticholic Acid, a Farnesoid X Receptor Agonist, Improves Portal Hypertension by Two Distinct Pathways in Cirrhotic Rats
Len Verbeke et al.
HEPATOLOGY (2014)
Macrophage heterogeneity in liver injury and fibrosis
Frank Tacke et al.
JOURNAL OF HEPATOLOGY (2014)
Hepatic Macrophages But Not Dendritic Cells Contribute to Liver Fibrosis by Promoting the Survival of Activated Hepatic Stellate Cells in Mice
Jean-Philippe Pradere et al.
HEPATOLOGY (2013)
Chemokine Receptor CXCR6-Dependent Hepatic NK T Cell Accumulation Promotes Inflammation and Liver Fibrosis
Alexander Wehr et al.
JOURNAL OF IMMUNOLOGY (2013)
Class II HDAC Inhibition Hampers Hepatic Stellate Cell Activation by Induction of MicroRNA-29
Inge Mannaerts et al.
PLOS ONE (2013)
Gene Expression Profiling of Early Hepatic Stellate Cell Activation Reveals a Role for Igfbp3 in Cell Migration
Inge Mannaerts et al.
PLOS ONE (2013)
Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology
Ingmar Mederacke et al.
NATURE COMMUNICATIONS (2013)
Experimental liver fibrosis research: update on animal models, legal issues and translational aspects
Christian Liedtke et al.
FIBROGENESIS & TISSUE REPAIR (2013)
Farnesoid X receptor targeting to treat nonalcoholic steatohepatitis
Luciano Adorini et al.
DRUG DISCOVERY TODAY (2012)
Leptin-mediated reactive oxygen species production does not significantly affect primary mouse hepatocyte functions in vitro
Ben Schroyen et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2012)
HSC-specific inhibition of Rho-kinase reduces portal pressure in cirrhotic rats without major systemic effects
Sabine Klein et al.
JOURNAL OF HEPATOLOGY (2012)
Atorvastatin inhibits proliferation and apoptosis, but induces senescence in hepatic myofibroblasts and thereby attenuates hepatic fibrosis in rats
Sabine Klein et al.
LABORATORY INVESTIGATION (2012)
Pathogenesis of Liver Fibrosis
Virginia Hernandez-Gea et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 6 (2011)
Mechanisms of hepatic fibrogenesis
Ursula E. Lee et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2011)
Activation of bile salt nuclear receptor FXR is repressed by pro-inflammatory cytokines activating NF-κB signaling in the intestine
Raffaella M. Gadaleta et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2011)
Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease
Raffaella M. Gadaleta et al.
GUT (2011)
Tissue-specific function of farnesoid X receptor in liver and intestine
Yan Zhu et al.
PHARMACOLOGICAL RESEARCH (2011)
Bench-to-beside review: Acute-on-chronic liver failure - linking the gut, liver and systemic Circulation
Len Verbeke et al.
CRITICAL CARE (2011)
Chronic Administration of Valproic Acid Inhibits Activation of Mouse Hepatic Stellate Cells In Vitro and In Vivo
Inge Mannaerts et al.
HEPATOLOGY (2010)
New insights into the antifibrotic effects of sorafenib on hepatic stellate cells and liver fibrosis
Yan Wang et al.
JOURNAL OF HEPATOLOGY (2010)
Atorvastatin attenuates hepatic fibrosis in rats after bile duct ligation via decreased turnover of hepatic stellate cells
Jonel Trebicka et al.
JOURNAL OF HEPATOLOGY (2010)
Evolving challenges in hepatic fibrosis
Scott L. Friedman
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2010)
Farnesoid X Receptor Critically Determines the Fibrotic Response in Mice but Is Expressed to a Low Extent in Human Hepatic Stellate Cells and Periductal Myofibroblasts
Peter Fickert et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
CCR2 Promotes Hepatic Fibrosis in Mice
Ekihiro Seki et al.
HEPATOLOGY (2009)
The Bile Acid Sensor Farnesoid X Receptor Is a Modulator of Liver Immunity in a Rodent Model of Acute Hepatitis
Andrea Mencarelli et al.
JOURNAL OF IMMUNOLOGY (2009)
Mechanisms of hepatic fibrogenesis
Scott L. Friedman
GASTROENTEROLOGY (2008)
Farnesoid X Receptor Antagonizes Nuclear Factor κB in Hepatic Inflammatory Response
Yan-Dong Wang et al.
HEPATOLOGY (2008)
NF-κB is a critical regulator of the survival of rodent and human hepatic myofibroblasts
Martha R. Watson et al.
JOURNAL OF HEPATOLOGY (2008)
Profibrogenic transforming growth Factor-β/Activin receptor-like kinase 5 signaling via connective tissue growth factor expression in hepatocytes
Hong-Lei Weng et al.
HEPATOLOGY (2007)
Nuclear factor-κB and the hepatic inflammation-fibrosis-cancer axis
Ahmed M. Elsharkawy et al.
HEPATOLOGY (2007)
Concomitant activation of the JAK/STAT, PI3K/AKT, and ERK signaling is involved in leptin-mediated promotion of invasion and migration of hepatocellular carcinoma cells
Neeraj K. Saxena et al.
CANCER RESEARCH (2007)
Spontaneous development of liver tumors in the absence of the bile acid receptor farnesoid X receptor
Fan Yang et al.
CANCER RESEARCH (2007)
Nitroflurbiprofen, a nitric oxide-releasing cyclooxygenase inhibitor, improves cirrhotic portal hypertension in rats
Wim Laleman et al.
GASTROENTEROLOGY (2007)
Emerging insights into transforming growth factor β Smad signal in hepatic fibrogenesis
Y. Inagaki et al.
GUT (2007)
Reversal effect of thalidomide on established hepatic cirrhosis in rats via inhibition of nuclear factor-kappa B/inhibitor of nuclear factor-kappa B pathway
Peng Lv et al.
ARCHIVES OF MEDICAL RESEARCH (2007)
A stable model of cirrhotic portal hypertension in the rat: thioacetamide revisited
W Laleman et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2006)
Portal hypertension: from pathophysiology to clinical practice
W Laleman et al.
LIVER INTERNATIONAL (2005)
Inhibition of inhibitor of kappa B kinases stimulates hepatic stellate cell apoptosis and accelerated recovery from rat liver fibrosis
F Oakley et al.
GASTROENTEROLOGY (2005)
Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis
L Xu et al.
GUT (2005)
The nuclear receptor SHP mediates inhibition of hepatic stellate cells by FXR and protects against liver fibrosis
S Fiorucci et al.
GASTROENTEROLOGY (2004)
6α-ethyl-chenodeoxycholic acid (6-ECDCA), a potent and selective FXR agonist endowed with anticholestatic activity
R Pellicciari et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Inhibition of apoptosis of activated hepatic stellate cells by tissue inhibitor of metalloproteinase-1 is mediated via effects on matrix metalloproteinase inhibition - Implications for reversibility of liver fibrosis
FR Murphy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Hepatic stellate cell/myofibroblast subpopulations in fibrotic human and rat livers
D Cassiman et al.
JOURNAL OF HEPATOLOGY (2002)
分享论文
